Skip to main content
. 2021 Nov 4;37(3):489–498. doi: 10.1111/jgh.15717

Figure 2.

Figure 2

Kaplan–Meier curves showing the development of (a) chronic bowel dysfunction (CBD), (b) dyspeptic symptoms, and (c) their overlap and (d) irritable bowel syndrome (IBS), (e) uninvestigated dyspepsia (UD), and (f) their overlap during six month follow‐up among patients with coronavirus disease‐19 (COVID‐19) as compared with healthy controls. Inline graphic, Case; Inline graphic, Control.